NEUROCRINE BIOSCIENCES INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.9 | $2.4 | $1.9 | $1.5 | $1.1 |
| Operating income | $0.6 | $0.6 | $0.3 | $0.2 | $0.1 |
| Net income | $0.5 | $0.3 | $0.2 | $0.2 | $0.1 |
| Cash Flow Statement | |||||
| Free cash flow | $0.7 | $0.6 | $0.4 | $0.3 | $0.2 |
| Share repurchases | $0.2 | $0.3 | $0.0 | $0.0 | — |
Shares outstanding 101.6M · Free float 93.0%
Annual filing data through FY ended December 31, 2025; float as of October 8, 2026.